The purpose of this study was to determine whether the nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester (l-NAME) demonstrates significant muscarinic-receptor antagonism during methacholine (MCh)-stimulated sweating in human forearm skin. Three intradermal microdialysis probes were placed in the skin of eight healthy adults (4 men and 4 women). MCh in the range of 0.033–243 mM in nine steps was perfused through a microdialysis probe with and without the presence of the nitric oxide synthase inhibitor l-NAME (10 mM) or the l-arginine analog NG-monomethyl-l-arginine (l-NMMA; 10 mM). Local sweat rate (sweat rate) and skin blood flow (laser-Doppler velocimetry) were measured directly over each microdialysis probe. We observed similar resting sweat rates at MCh only, MCh and l-NAME, and MCh and l-NMMA sites averaging 0.175 ± 0.029, 0.186 ± 0.034, and 0.139 ± 0.027 mg·min−1·cm−2, respectively. Peak sweat rate (0.46 ± 0.11, 0.56 ± 0.16, and 0.53 ± 0.16. mg·min−1·cm−2) was also similar among all three sites. MCh produced a sigmoid-shape dose-response curve and 50% of the maximal attainable response (0.42 ± 0.14 mM for MCh only) was shifted rightward shift in the presence of l-NAME or l-NMMA (2.88 ± 0.79 and 3.91 ± 1.14 mM, respectively; P < 0.05). These results indicate that nitric oxide acts to augment MCh-stimulated sweat gland function in human skin. In addition, l-NAME consistently blunted the MCh-induced vasodilation, whereas l-NMMA did not. These data support the hypothesis that muscarinic-induced dilation in cutaneous blood vessels is not mediated by nitric oxide production and that the role of l-NAME in attenuating acetylcholine-induced vasodilation may be due to its potential to act as a muscarinic-receptor antagonist.
Myocardial infarction (MI) is the leading cause of death from coronary heart disease and requires immediate reperfusion therapy with thrombolysis, primary percutaneous coronary intervention, or coronary artery bypass grafting. However, myocardial reperfusion therapy is often accompanied by cardiac ischemia/reperfusion (I/R) injury, which leads to myocardial injury with detrimental consequences. The causes of I/R injury are unclear, but are multifactorial, including free radicals, reactive oxygen species, calcium overload, mitochondria dysfunction, inflammation, and neutrophil-mediated vascular injury. Mild hypothermia has been introduced as one of the potential inhibitors of myocardial I/R injury. Although animal studies have demonstrated that mild hypothermia significantly reduces or delays I/R myocardium damage, human trials have not shown clinical benefits in acute MI (AMI). In addition, the practice of hypothermia treatment is increasing in various fields such as surgical anesthesia and intensive care units. Adequate sedation for anesthetic procedures and protection from body shivering has become essential during therapeutic hypothermia. Therefore, anesthesiologists should be aware of the effects of therapeutic hypothermia on the metabolism of anesthetic drugs. In this paper, we review the existing data on the use of therapeutic hypothermia for AMI in animal models and human clinical trials to better understand the discrepancy between perceived benefits in preclinical animal models and the absence thereof in clinical trials thus far.
Nephrolithiasis is one of the most common urinary disorders in dogs. Although a majority of kidney calculi are non-obstructive and are likely to be asymptomatic, they can lead to parenchymal loss and obstruction as they progress. Thus, early diagnosis of kidney calculi is important for patient monitoring and better prognosis. However, detecting kidney calculi and monitoring changes in the sizes of the calculi from computed tomography (CT) images is time-consuming for clinicians. This study, in a first of its kind, aims to develop a deep learning model for automatic kidney calculi detection using pre-contrast CT images of dogs. A total of 34,655 transverseimage slices obtained from 76 dogs with kidney calculi were used to develop the deep learning model. Because of the differences in kidney location and calculi sizes in dogs compared to humans, several processing methods were used. The first stage of the models, based on the Attention U-Net (AttUNet), was designed to detect the kidney for the coarse feature map. Five different models–AttUNet, UTNet, TransUNet, SwinUNet, and RBCANet–were used in the second stage to detect the calculi in the kidneys, and the performance of the models was evaluated. Compared with a previously developed model, all the models developed in this study yielded better dice similarity coefficients (DSCs) for the automatic segmentation of the kidney. To detect kidney calculi, RBCANet and SwinUNet yielded the best DSC, which was 0.74. In conclusion, the deep learning model developed in this study can be useful for the automated detection of kidney calculi.
Seon Hee Oh, Suk Whee Kim, Dong Joon Kim, Sang Hun Kim, Kyung Joon Lim, Kichang Lee, and Ki Tae Jung. Korean J Pain 2021;34:405-16. https://doi.org/10.3344/kjp.2021.34.4.405